ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
0,19
-0,0011
(-0,58%)
Fermé 21 Décembre 10:00PM
0,1962
0,0062
(3,26%)
Après les heures de négociation: 1:42AM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,1962
Prix Achat
-
Prix Vente
-
Volume échangé
344 242
0,1852 Fourchette du Jour 0,199
0,1628 Plage de 52 semaines 0,62
Cap du marché
Clôture Veille
0,1911
Ouverture
0,1892
Dernière Transaction
50108
@
0.19
Dernière heure de transaction
Volume financier
US$ 66 719
VWAP
0,193813
Volume moyen (3 m)
445 205
Actions en circulation
63 706 446
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,96
Bénéfice par action (BPA)
-0,45
Chiffre d'affairess
202k
Bénéfice net
-28,96M

À propos de AIM ImmunoTech Inc

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alfero... AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. The company is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Wilmington, Delaware, USA
Fondé
-
AIM ImmunoTech Inc est coté dans le secteur Biological Pds,ex Diagnstics de la American Stock Exchange avec le ticker AIM. Le dernier cours de clôture d'AIM ImmunoTech était de US$0,19. Au cours de la dernière année, les actions de AIM ImmunoTech ont été négociées dans une fourchette de prix de US$ 0,1628 à US$ 0,62.

AIM ImmunoTech compte actuellement 63 706 446 actions en circulation. La capitalisation boursière d'AIM ImmunoTech est de US$12,17 million. AIM ImmunoTech a un ratio cours/bénéfice (ratio PE) de -3.96.

AIM Dernières nouvelles

AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

OCALA, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that it received a notice (the “Notice”) from the NYSE American...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0167-7.844058243310.21290.2250.18654362780.20202945CS
4-0.0155-7.321681624940.21170.2440.18653737710.2115237CS
12-0.0838-29.92857142860.280.2890.16284452050.22550803CS
26-0.1938-49.69230769230.390.42950.16283494660.26777379CS
52-0.3028-60.68136272550.4990.620.16282909360.33255823CS
156-0.9438-82.78947368421.141.380.16282372990.60404884CS
260-0.2619-57.17092337920.45818.750.162813560262.49002481CS

AIM - Frequently Asked Questions (FAQ)

What is the current AIM ImmunoTech share price?
The current share price of AIM ImmunoTech is US$ 0,1962
How many AIM ImmunoTech shares are in issue?
AIM ImmunoTech has 63 706 446 shares in issue
What is the market cap of AIM ImmunoTech?
The market capitalisation of AIM ImmunoTech is USD 12,17M
What is the 1 year trading range for AIM ImmunoTech share price?
AIM ImmunoTech has traded in the range of US$ 0,1628 to US$ 0,62 during the past year
What is the PE ratio of AIM ImmunoTech?
The price to earnings ratio of AIM ImmunoTech is -3,96
What is the cash to sales ratio of AIM ImmunoTech?
The cash to sales ratio of AIM ImmunoTech is 562,5
What is the reporting currency for AIM ImmunoTech?
AIM ImmunoTech reports financial results in USD
What is the latest annual turnover for AIM ImmunoTech?
The latest annual turnover of AIM ImmunoTech is USD 202k
What is the latest annual profit for AIM ImmunoTech?
The latest annual profit of AIM ImmunoTech is USD -28,96M
What is the registered address of AIM ImmunoTech?
The registered address for AIM ImmunoTech is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the AIM ImmunoTech website address?
The website address for AIM ImmunoTech is www.aimimmuno.com
Which industry sector does AIM ImmunoTech operate in?
AIM ImmunoTech operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGLDMarygold Companies Inc
US$ 2,053
(48,77%)
128,45k
MINFT Limited
US$ 7,25
(44,22%)
948,89k
CTMCastellum Inc
US$ 0,578
(41,01%)
8,94M
KULRKULR Technology Group Inc
US$ 2,885
(28,79%)
75,72M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 12,49
(22,81%)
64,96M
BATLBattalion Oil Corporation
US$ 1,3499
(-44,56%)
1,63M
NVOXDefiance Daily Target 2x Long Nvo ETF
US$ 11,5991
(-35,47%)
406,44k
UVIX2x Long VIX Futures ETF
US$ 3,83
(-29,07%)
70,31M
TPETTrio Petroleum Corp
US$ 1,10
(-25,17%)
2,79M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 19,235
(-23,06%)
21,21M
SPYSPDR S&P 500
US$ 591,15
(0,86%)
122,49M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6,1628
(-3,25%)
114,87M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 27,30
(3,80%)
108,08M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,435
(7,27%)
94,23M
KULRKULR Technology Group Inc
US$ 2,885
(28,79%)
75,72M
Aucune Discussion Trouvée
Ajouter une Discussion